pharmaceuticals
pharmaceuticals Articles
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be acquiring the firm.
Published:
Xeris Pharmaceuticals shares pushed higher on Tuesday after the firm announced positive topline results from its midstage study in adults with Type 1 diabetes mellitus.
Published:
Apellis Pharmaceuticals shares jumped on Tuesday after the firm announced positive results from its late stage study in adults with paroxysmal nocturnal hemoglobinuria (PNH). Specifically, the data...
Published:
On a company by company basis, investing in biotechs is somewhat tricky. However, there is an investment strategy that makes it much easier.
Published:
Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want to lower prescription drug costs....
Published:
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Published:
AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.
Published:
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Published:
NewLink Genetics and Merck shares made handy gains on Friday after it was announced that the FDA has granted approval to Ervebo, the Zaire Ebola virus vaccine V920.
Published:
Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.
Published:
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of December.
Published:
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published: